10900 NE 4th Street
Suite 2300
Bellevue, WA 98004
United States
425 635 7700
https://www.bellevuespac.com
Sector(es): Financial Services
Industria: Shell Companies
Empleados a tiempo completo:
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Kuk Hyoun Hwang | CEO & Director | N/D | N/D | 1976 |
Mr. David Jin Yoo | Chief Financial Officer | N/D | N/D | 1974 |
Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.
La calificación ISS Governance QuickScore de Bellevue Life Sciences Acquisition Corp. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.